Modified Huangqi Chifeng decoction inhibits excessive autophagy to protect against Doxorubicin‑induced nephrotic syndrome in rats via the PI3K/mTOR signaling pathway

Yu,Zi‑Kai; Yang,Bin; Zhang,Yu; Li,Liu‑Sheng; Zhao,Jin‑Ning; Hao,Wei

doi:10.3892/etm.2018.6492

Modified Huangqi Chifeng decoction inhibits excessive autophagy to protect against Doxorubicin‑induced nephrotic syndrome in rats via the PI3K/mTOR signaling pathway

Authors:
- Zi‑Kai Yu
- Bin Yang
- Yu Zhang
- Liu‑Sheng Li
- Jin‑Ning Zhao
- Wei Hao
View Affiliations

Affiliations: Department of Nephropathy, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, P.R. China, Department of Pathology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, P.R. China, Experimental Research Center, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, P.R. China
Published online on: July 20, 2018 https://doi.org/10.3892/etm.2018.6492
Pages: 2490-2498
Copyright: © Yu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate whether modified Huangqi Chifeng decoction (MHCD) could be an effective treatment against Doxorubicin‑induced nephrosis in rats and whether it regulates autophagy via the phosphoinositide‑3 kinase/mammalian target of rapamycin (PI3K/mTOR) signaling pathway. A total of 40 male Sprague‑Dawley rats were randomly divided into blank, model, telmisartan and MHCD groups. The rat model of nephrosis was induced by intragastric administration of Doxorubicin for 8 weeks. Rats were housed in metabolic cages and urine was collected once every 2 weeks to measure 24‑h protein levels. Blood samples were obtained from the abdominal aorta and levels of albumin (ALB), total cholesterol (TCH), triacylglyceride (TG) and serum creatinine (Scr) were assessed. Renal pathological changes were examined using hematoxylin‑eosin, Masson's trichome and periodic acid‑Schiff staining. Podocytes and autophagosomes were observed using an electron microscope. The expression and distribution of microtubule‑associated proteins 1A/1B light chain 3B (LC3), LC3‑I, LC3‑II, beclin‑1, PI3K and mTOR were determined using immunohistochemistry and western blotting. At weeks 6 and 8, 24‑h proteinuria significantly decreased in the MHCD group compared with the model group (P<0.05). Compared with the model group, the MHCD group exhibited significantly reduced levels of TG, TCH and Scr, as well as significantly increased ALB levels (P<0.05). MHCD was demonstrated to prevent glomerular and podocyte injury. The number of autophagosomes was significantly decreased and the expression of beclin‑1, LC3, LC3‑I and LC3‑II was inhibited following MHCD treatment compared with the model group (P<0.05). MHCD treatment significantly increased the expression of PI3K and mTOR in Doxorubicin nephrotic rats compared with the model group (P<0.05). In conclusion, MHCD was demonstrated to ameliorate proteinuria and protect against glomerular and podocyte injury by inhibiting excessive autophagy via the PI3K/mTOR signaling pathway.

View Figures

View References

1	Kirsztajn GM, Filho NS, Draibe SA, Netto MV, Thomé FS, Souza E and Bastos MG: Fast reading of the KDIGO 2012: Guidelines for evaluation and management of chronic kidneydisease in clinical practice. J Bras Nefrol. 36:63–73. 2014.(In Portuguese). View Article : Google Scholar : PubMed/NCBI
2	Mills KT, Xu Y, Zhang W, Bundy JD, Chen CS, Kelly TN, Chen J and He J: A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 88:950–957. 2015. View Article : Google Scholar : PubMed/NCBI
3	Carney EF: Epidemiology: Global burden of disease study 2013 reports that disability caused by CKD is increasing worldwide. Nat Rev Nephrol. 11:4462015. View Article : Google Scholar : PubMed/NCBI
4	Barnett AH, Bain SC, Bouter P, Karlberg B, Madsbad S, Jervell J and Mustonen J; Diabetics Exposed to Telmisartan and Enalapril Study Group, : Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. N Engl J Med. 351:1952–1961. 2004. View Article : Google Scholar : PubMed/NCBI
5	Gong XZ, Zhou LF, Wang Q, Tang XC, Qian YR, Wang YR, Lu L and Zhou JJ: Effect of Chuanhuang No.1 recipe on renal function and micro-inflammation in phase 3 chronic kidney disease patients. Zhongguo Zhong Xi Yi Jie He Za Zhi. 35:137–141. 2015.(In Chinese). PubMed/NCBI
6	Dong F, Cheng J, Lin S, Hu Z, Chen G and He L: The clinical research on serum cystatin-C alteration on stage II chronic kidney disease with gubenquduyishen decoction treatment. J Ethnopharmacol. 131:581–584. 2010. View Article : Google Scholar : PubMed/NCBI
7	Zhang Yu: Clinical observation on 50 cases of chronic nephritis proteinuria treated with modified Huangqi Chifeng Decoction. Chin Med Guides. 36:137–138. 2007.(In Chinese).
8	Clark SL Jr: Cellular differentiation in the kidneys of newborn mice studied with the electron microscope. J Biophys Biochem Cytol. 3:349–362. 1957. View Article : Google Scholar : PubMed/NCBI
9	Berkenstam A, Ahlberg J and Glaumann H: Isolation and characterization of autophagic vacuoles from rat kidney cortex. Virchows Arch B Cell Pathol Incl Mol Pathol. 44:275–286. 1983. View Article : Google Scholar : PubMed/NCBI
10	Asanuma K, Tanida I, Shirato I, Ueno T, Takahara H, Nishitani T, Kominami E and Tomino Y: MAP-LC3, a promising autophagosomal marker, is processed during the differentiation and recovery of podocytes from PAN nephrosis. FASEB J. 17:1165–1167. 2003. View Article : Google Scholar : PubMed/NCBI
11	Mizushima N, Yamamoto A, Matsui M, Yoshimori T and Ohsumi Y: In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell. 15:1101–1104. 2004. View Article : Google Scholar : PubMed/NCBI
12	Hartleben B, Gödel M, Meyer-Schwesinger C, Liu S, Ulrich T, Köbler S, Wiech T, Grahammer F, Arnold SJ, Lindenmeyer MT, et al: Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J Clin Invest. 120:1084–1096. 2010. View Article : Google Scholar : PubMed/NCBI
13	Zeng C, Fan Y, Wu J, Shi S, Chen Z, Zhong Y, Zhang C, Zen K and Liu Z: Podocyte autophagic activity plays a protective role in renal injury and delays the progression of podocytopathies. J Pathol. 234:203–213. 2014.PubMed/NCBI
14	Yu Z, Yang B and Zhang Y: Protective effect of modified Huangqi Chifeng decoction on Doxorubicin Nephrosis (AN) rats kidney and its regulated effect on its autophagy level. Zhongguo Zhong Yi Ji Chu Yi Xue Za Zhi. 23:477–479+563. 2017.(In Chinese).
15	Faleiros CM, Francescato HD, Papoti M, Chaves L, Silva CG, Costa RS and Coimbra TM: Effects of previous physical training on adriamycin nephropathy and its relationship with endothelial lesions and angiogenesis in the renal cortex. Life Sci. 169:43–51. 2017. View Article : Google Scholar : PubMed/NCBI
16	Lee VW and Harris DC: Adriamycin nephropathy: A model of focal segmental glomerulosclerosis. Nephrology (Carlton). 16:30–38. 2011. View Article : Google Scholar : PubMed/NCBI
17	Rahman M, Yang W, Akkina S, Alper A, Anderson AH, Appel LJ, He J, Raj DS, Schelling J, Strauss L, et al: Relation of serum lipids and lipoproteins with progression of CKD: The CRIC study. Clin J Am Soc Nephrol. 9:1190–1198. 2014. View Article : Google Scholar : PubMed/NCBI
18	Liu N, Xu L, Shi Y and Zhuang S: Podocyte autophagy: A potential therapeutic target to prevent the progression of diabetic nephropathy. J Diabetes Res. 2017:35602382017. View Article : Google Scholar : PubMed/NCBI
19	Mijaljica D, Prescott M and Devenish RJ: The intriguing life of autophagosomes. Int J Mol Sci. 13:3618–3635. 2012. View Article : Google Scholar : PubMed/NCBI
20	Stern ST, Adiseshaiah PP and Crist RM: Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity. Part Fibre Toxicol. 9:202012. View Article : Google Scholar : PubMed/NCBI
21	Guan H, Piao H, Qian Z, Zhou X, Sun Y, Gao C, Li S and Piao F: 2,5-Hexanedione induces autophagic death of VSC4.1 cells via a PI3K/Akt/mTOR pathway. Mol Biosyst. 13:1993–2005. 2017. View Article : Google Scholar : PubMed/NCBI
22	Wang Z, Wang ZG and Liu Z: Changes of glomerular fixed anionic charge sites in adriamycin nephrosis in rats. Chin Med J (Engl). 104:128–131. 1991.PubMed/NCBI
23	Bertani T, Poggi A, Pozzoni R, Delaini F, Sacchi G, Thoua Y, Mecca G, Remuzzi G and Donati MB: Adriamycin-induced nephrotic syndrome in rats: Sequence of pathologic events. Lab Invest. 46:16–23. 1982.PubMed/NCBI
24	Wang YL, Zhang Y, Wang HX and Hao W: Impact of jiaweihuangqichifeng decoction on proteinuria, renal cortex SOD and renal cortex MDA in nephrotic rats induced by adriamycin. Chin J Basic Med Trad Chin Med. 17:505–507. 2011.(In Chinese).
25	Costas MA and Rubio MF: Autophagy: A strategy for cell survival. Medicina (B Aires). 77:314–320. 2017.(In Spanish). PubMed/NCBI
26	Yao ST and Qin SC: The relationship of autophagy with endoplasmic reticulum stress and its role in pathogenesis, prevention and therapy of atherosclerosis. Sheng Li Xue Bao. 69:515–521. 2017.(In Chinese). PubMed/NCBI
27	He C and Klionsky DJ: Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet. 43:67–93. 2009. View Article : Google Scholar : PubMed/NCBI
28	Davis S, Wang J and Ferro-Novick S: Crosstalk between the secretory and autophagy pathways regulates autophagosome formation. Dev Cell. 41:23–32. 2017. View Article : Google Scholar : PubMed/NCBI
29	Tanida I, Ueno T and Kominami E: LC3 and autophagy. Methods Mol Biol. 445:77–88. 2008. View Article : Google Scholar : PubMed/NCBI
30	Shibata M, Yoshimura K, Tamura H, Ueno T, Nishimura T, Inoue T, Sasaki M, Koike M, Arai H, Kominami E and Uchiyama Y: LC3, a microtubule-associated protein1A/B light chain3, is involved in cytoplasmic lipid droplet formation. Biochem Biophys Res Commun. 393:274–279. 2010. View Article : Google Scholar : PubMed/NCBI
31	Tanida I, Ueno T and Kominami E: LC3 conjugation system in mammalian autophagy. Int J Biochem Cell Biol. 36:2503–2518. 2004. View Article : Google Scholar : PubMed/NCBI
32	Glover K, Li Y, Mukhopadhyay S, Leuthner Z, Chakravarthy S, Colbert CL and Sinha SC: Structural transitions in conserved, ordered Beclin 1 domains essential to regulating autophagy. J Biol Chem. 292:16235–16248. 2017. View Article : Google Scholar : PubMed/NCBI
33	Mei Y, Glover K, Su M and Sinha SC: Conformational flexibility of BECN1: Essential to its key role in autophagy and beyond. Protein Sci. 25:1767–1785. 2016. View Article : Google Scholar : PubMed/NCBI
34	Kang R, Zeh HJ, Lotze MT and Tang D: The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 18:571–580. 2011. View Article : Google Scholar : PubMed/NCBI
35	Yin Z, Pascual C and Klionsky DJ: Autophagy: Machinery and regulation. Microb Cell. 3:588–596. 2016. View Article : Google Scholar : PubMed/NCBI
36	Ravikumar B, Sarkar S, Davies JE, Futter M, Garcia-Arencibia M, Green-Thompson ZW, Jimenez-Sanchez M, Korolchuk VI, Lichtenberg M, Luo S, et al: Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev. 90:1383–1435. 2010. View Article : Google Scholar : PubMed/NCBI
37	Martinet W, Agostinis P, Vanhoecke B, Dewaele M and De Meyer GR: Autophagy in disease: A double-edged sword with therapeutic potential. Clin Sci (Lond). 116:697–712. 2009. View Article : Google Scholar : PubMed/NCBI
38	Kroemer G and Jäättelä M: Lysosomes and autophagy in cell death control. Nat Rev Cancer. 5:886–897. 2005. View Article : Google Scholar : PubMed/NCBI
39	Johnson-Lyles DN, Peifley K, Lockett S, Neun BW, Hansen M, Clogston J, Stern ST and McNeil SE: Fullerenol cytotoxicity in kidney cells is associated with cytoskeleton disruption, autophagic vacuole accumulation, and mitochondrial dysfunction. Toxicol Appl Pharmacol. 248:249–258. 2010. View Article : Google Scholar : PubMed/NCBI
40	Klionsky DJ: Autophagy: From phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol. 11:931–937. 2007. View Article : Google Scholar
41	Peng Y, Qiu L, Xu D, Zhang L, Yu H, Ding Y, Deng L and Lin J: M4IDP, a zoledronic acid derivative, induces G1 arrest, apoptosis and autophagy in HCT116 colon carcinoma cells via blocking PI3K/Akt/mTOR pathway. Life Sci. 185:63–72. 2017. View Article : Google Scholar : PubMed/NCBI
42	Wang S, Li J, Du Y, Xu Y, Wang Y, Zhang Z, Xu Z, Zeng Y, Mao X and Cao B: The class I PI3K inhibitor S14161 induces autophagy in malignant blood cells by modulating the Beclin 1/Vps34 complex. J Pharmacol Sci. 134:197–202. 2017. View Article : Google Scholar : PubMed/NCBI
43	De Santis MC, Sala V, Martini M, Ferrero GB and Hirsch E: PI3K signaling in tissue hyper-proliferation: From overgrowth syndromes to kidney cysts. Cancers (Basel). 9(pii): E302017. View Article : Google Scholar : PubMed/NCBI
44	Reilly R, Mroz MS, Dempsey E, Wynne K, Keely SJ, McKone EF, Hiebel C, Behl C and Coppinger JA: Targeting the PI3K/Akt/mTOR signalling pathway in cystic fibrosis. Sci Rep. 7:76422017. View Article : Google Scholar : PubMed/NCBI
45	Luo T, Liu G, Ma H, Lu B, Xu H, Wang Y, Wu J, Ge P and Liang J: Inhibition of autophagy via activation of PI3K/Akt pathway contributes to the protection of ginsenoside Rb1 against neuronal death caused by ischemic insults. Int J Mol Sci. 15:15426–15442. 2014. View Article : Google Scholar : PubMed/NCBI
46	Oh I, Cho H and Lee Y, Cheon M, Park D and Lee Y: Blockage of autophagy rescues the dual PI3K/mTOR Inhibitor BEZ235-induced growth inhibition of colorectal cancer cells. Dev Reprod. 20:1–10. 2016. View Article : Google Scholar : PubMed/NCBI
47	Echeverry N, Ziltener G, Barbone D, Weder W, Stahel RA, Broaddus VC and Felley-Bosco E: Inhibition of autophagy sensitizes malignant pleural mesothelioma cells to dual PI3K/mTOR inhibitors. Cell Death Dis. 6:e17572015. View Article : Google Scholar : PubMed/NCBI
48	Wang Y, Wang W, Li D, Li M, Wang P, Wen J, Liang M, Su B and Yin Y: IGF-1 alleviates NMDA-induced excitotoxicity in cultured hippocampal neurons against autophagy via the NR2B/PI3K-AKT-mTOR pathway. J Cell Physiol. 229:1618–1629. 2014. View Article : Google Scholar : PubMed/NCBI
49	Xing Y, Liu YX, Liu X, Wang SL, Li P, Lin XH, Sui CL, Xu C, Qi B and Tong Q: Effects of Gui Zhu Yi Kun formula on the P53/AMPK pathway of autophagy in granulosa cells of rats with polycystic ovary syndrome. Exp Ther Med. 13:3567–3573. 2017. View Article : Google Scholar : PubMed/NCBI
50	Li S: The effect of MHCD on proteinuria and its cellular molecular mechanism [D]. Beijing Zhong Yi Yao Da Xue. 2016.(In Chinese).